Singulex Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Singulex Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6566
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and physicians in identifying the biomarkers of disease. Singulex’s SMC technology offer ultrasensitive lab testing services for facilitating proactive health management. The company also provides immunoassay kits and reagents and immunoassay systems. It offers services such as clinical lab testing, patient lab testing, wellness programs, clinical laboratory consulting and billing and client services. The company’s technology is used for medical practice or clinical diagnostics and scientific research applications. Singulex is headquartered in Alameda, California, the US.

Singulex Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Singulex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Singulex Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Singulex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Singulex Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Singulex Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Singulex Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Singulex Raises US$55 Million In Financing Round 10
Singulex Raises US$12 Million In Series G Financing 11
Singulex Raises US$15.3 Million In Venture Financing 12
Singulex Secures USD15.34 Million in Series F Round of Fundingq 13
Partnerships 14
Singulex Enters into Licensing agreement with Thermo Fisher Scientific 14
Singulex Enters into Licensing Agreement with Grifols 15
Singulex Enters into Agreement with Qiagen 16
Singulex Forms Joint Venture with Technology Foundation STW 17
Singulex Enters into Development Agreement with CHDI Foundation 18
Singulex Enters Into Co-Development Agreement With Tecan 19
EMD Millipore Enters into Licensing Agreement with Singulex 20
Equity Offering 21
Grifols Invests USD50 Million in Singulex 21
Singulex Withdrawn IPO For Up To US$86 Million 22
Singulex Inc – Key Competitors 23
Singulex Inc – Key Employees 24
Singulex Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Singulex Inc, Medical Equipment, Key Facts 2
Singulex Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Singulex Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Singulex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Singulex Inc, Deals By Market, 2012 to YTD 2018 8
Singulex Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Singulex Raises US$55 Million In Financing Round 10
Singulex Raises US$12 Million In Series G Financing 11
Singulex Raises US$15.3 Million In Venture Financing 12
Singulex Secures USD15.34 Million in Series F Round of Fundingq 13
Singulex Enters into Licensing agreement with Thermo Fisher Scientific 14
Singulex Enters into Licensing Agreement with Grifols 15
Singulex Enters into Agreement with Qiagen 16
Singulex Forms Joint Venture with Technology Foundation STW 17
Singulex Enters into Development Agreement with CHDI Foundation 18
Singulex Enters Into Co-Development Agreement With Tecan 19
EMD Millipore Enters into Licensing Agreement with Singulex 20
Grifols Invests USD50 Million in Singulex 21
Singulex Withdrawn IPO For Up To US$86 Million 22
Singulex Inc, Key Competitors 23
Singulex Inc, Key Employees 24
Singulex Inc, Joint Venture 25

List of Figures
Singulex Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Singulex Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Singulex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Singulex Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Singulex Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alberta Investment Management Corporation:企業の戦略・SWOT・財務情報
    Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report Summary Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Owensboro Municipal Utilities:発電所・企業SWOT分析
    Owensboro Municipal Utilities - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Sirona Biochem Corp (SBM):製薬・医療:M&Aディール及び事業提携情報
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It provides cosmeceutical programs such as development of anti-aging and depigmenting agent …
  • Dermalogica Inc:企業の戦略・SWOT・財務情報
    Dermalogica Inc - Strategy, SWOT and Corporate Finance Report Summary Dermalogica Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Amarin Corp Plc (AMRN):企業の財務・戦略的SWOT分析
    Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • GW Pharmaceuticals Plc (GWP)-製薬・医療分野:企業M&A・提携分析
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, f …
  • Showa Denko Materials Co Ltd:企業の戦略的SWOT分析
    Showa Denko Materials Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Volkswagen AG:戦略・SWOT・企業財務分析
    Volkswagen AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Warpaint London plc (W7L):企業の財務・戦略的SWOT分析
    Warpaint London plc (W7L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • J.K. Cement Ltd. (JKCEMENT):企業の財務・戦略的SWOT分析
    J.K. Cement Ltd. (JKCEMENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • KKR & Co. L.P.:企業の戦略・SWOT・財務情報
    KKR & Co. L.P. - Strategy, SWOT and Corporate Finance Report Summary KKR & Co. L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • iVascular SLU:企業の製品パイプライン分析2018
    Summary iVascular SLU (iVascular) is a designer and developer of advanced medical devices and implants for the treatment of cardiovascular system disorders. The company offers products in the fields of interventional cardiology, endovascular intervention and interventional neuroradiology including d …
  • Range Resources Corporation:企業の戦略・SWOT・財務情報
    Range Resources Corporation - Strategy, SWOT and Corporate Finance Report Summary Range Resources Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • IMPAC Mortgage Holdings Inc (IMH):企業の財務・戦略的SWOT分析
    IMPAC Mortgage Holdings Inc (IMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Bank Audi SAL:企業の戦略・SWOT・財務分析
    Bank Audi SAL - Strategy, SWOT and Corporate Finance Report Summary Bank Audi SAL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Northwest Biotherapeutics Inc (NWBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer. The company by utilizing its proprietary technology platform, DCVax, developed a robust pipeline of therapeutic product candidates. DCVax is …
  • Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析
    Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sinopec Shanghai Petrochemical Company Limited:戦略・SWOT・企業財務分析
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Calavo Growers, Inc. (CVGW):企業の財務・戦略的SWOT分析
    Calavo Growers, Inc. (CVGW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • MSM Malaysia Holdings Berhad (MSM):企業の財務・戦略的SWOT分析
    MSM Malaysia Holdings Berhad (MSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆